Yes, order a CT chest with IV contrast (CTA) to fully characterize the pulmonary sequestration
In an asymptomatic patient with an incidentally discovered pulmonary sequestration on non-contrast calcium scoring CT, you should obtain contrast-enhanced CT imaging to definitively delineate the vascular anatomy, confirm the diagnosis, and guide management decisions.
Why Contrast Imaging is Essential
The non-contrast calcium scoring CT only partially visualized the lesion and identified systemic arterial supply from the thoracic aorta—this is insufficient for complete characterization. CTA chest (timed for aortic enhancement) is specifically designed to identify systemic arterial supply to pulmonary lesions 1. This imaging will:
- Confirm the diagnosis by clearly demonstrating the aberrant arterial supply from the descending aorta
- Define the complete vascular anatomy including the feeding artery's origin, course, and caliber
- Identify venous drainage (pulmonary veins vs systemic veins, which distinguishes intralobar from extralobar sequestration)
- Assess the extent of lung parenchymal involvement and any associated complications like cystic changes or infection
- Enable surgical planning if intervention becomes necessary 1
Specific Imaging Recommendation
Order a CTA chest with IV contrast (not CTPA). The contrast timing should be optimized for the aorta and its branches, not the pulmonary arteries 1. This protocol specifically evaluates systemic arterial supply, which is the hallmark of pulmonary sequestration.
Clinical Context and Management Implications
Recent case reports demonstrate that pulmonary sequestration is frequently diagnosed incidentally in asymptomatic adults, even in the 7th-8th decades of life 2, 3. While your patient is currently asymptomatic, complete characterization is critical because:
Diagnostic certainty matters: Pulmonary sequestration can mimic malignancy, infection, or other pathology on imaging 2, 4. CTA provides definitive diagnosis and avoids unnecessary biopsies or inappropriate treatment.
Risk stratification: Even asymptomatic sequestrations carry risks of recurrent infection, hemoptysis, and rarely hemothorax 5, 4, 6. Complete anatomic definition helps assess these risks.
Management decisions: While asymptomatic patients can be managed conservatively with surveillance imaging 2, 4, some experts recommend prophylactic resection to prevent future complications 5. You cannot make this decision without complete vascular mapping.
Surgical planning if needed: Should the patient develop symptoms or complications, pre-existing detailed vascular anatomy is invaluable for surgical planning 4, 7.
Important Caveats
- Air embolism risk is minimal with proper IV technique, and this concern should not prevent obtaining necessary diagnostic imaging 1
- Non-contrast CT alone is insufficient for pulmonary sequestration evaluation, despite adequate visualization of some vascular malformations 1
- The diagnosis period is typically >5 years from symptom onset 4, meaning your patient may develop symptoms in the future—having baseline complete imaging is prudent
Follow-up Algorithm
After CTA confirmation:
- If intralobar sequestration (drains to pulmonary veins, more common): Discuss with thoracic surgery. Options include surveillance imaging vs prophylactic resection 4
- If extralobar sequestration (drains to systemic veins, rare): Serial monitoring is appropriate for asymptomatic patients 4
- If any complications present (infection, cystic changes, hemoptysis): Surgical resection is indicated 5, 4, 7
The contrast study is not optional—it is the diagnostic standard for pulmonary sequestration and will directly impact your patient's management plan 2, 8, 4, 7.